$Very Severe and Refractory Noninfectious Cystitis in Patients with Systemic Lupus Erythematosus: Potential Role of Rituximab Therapy$

Very Severe and Refractory Noninfectious Cystitis in Patients with Systemic Lupus Erythematosus: Potential Role of Rituximab Therapy

Systemic lupus erythematosus (SLE) is a chronic inflammatory autoimmune disease with various clinical manifestations, including, rarely, a form of interstitial cystitis (lupus cystitis, LC). LC can be asymptomatic and usually has discrete symptoms that improve with conventional therapies available f...

Full description

Bibliographic Details
Main Authors:	Vanessa Ocampo-Piraquive, Inés Mondragón-Lenis, Juan G. De los Rios, Carlos A. Cañas
Format:	Article
Language:	English
Published:	Hindawi Limited 2021-01-01
Series:	Case Reports in Rheumatology
Online Access:	http://dx.doi.org/10.1155/2021/6610111

Similar Items

Rituximab for Remission Induction and Maintenance in Refractory Systemic Lupus Erythematosus
by: Fabio Bonilla-Abadía, et al.
Published: (2014-01-01)

Rituximab Followed by Belimumab Controls Severe Lupus Nephritis and Bullous Pemphigoid in Systemic Lupus Erythematosus Refractory to Several Combination Therapies
by: Luca Petricca, et al.
Published: (2020-10-01)

Noninfectious Causes of Fever in 128 Patients with Systemic Lupus Erythematosus
by: Feng GUO, et al.
Published: (2019-01-01)

Lupus cystitis: An unusual presentation of systemic lupus erythematosus
by: S Mukhopadhyay, et al.
Published: (2014-01-01)

Rituximab in the management of systemic lupus erythematosus
by: Adrian Levitsky, et al.
Published: (2013-06-01)

Experience of Using Rituximab in a Girl with Severe Systemic Lupus Erythematosus
by: A. A. Lebedenko, et al.
Published: (2015-10-01)

Long-term follow-up of patients with refractory systemic lupus erythematosus during rituximab treatment
by: M É Tsanian, et al.
Published: (2014-05-01)

Multicenter Retrospective Analysis of the Effectiveness and Safety of Rituximab in Korean Patients with Refractory Systemic Lupus Erythematosus
by: So-Young Bang, et al.
Published: (2012-01-01)

Successful treatment of a patient with refractory immune thrombocytopenic purpura in systemic lupus erythematosus with rituximab
by: Kazuya Abe, et al.
Published: (2019-10-01)

Response to rituximab in a refractory case of thrombotic thrombocytopenic purpura associated with systemic lupus erythematosus
by: Niaz Faraz, et al.
Published: (2010-01-01)

Rituximab treatment efficacy in a patient with systemic lupus erythematosus with severe thrombocytopenia
by: Alexandrova O.L., et al.
Published: (2018-09-01)

Efficacy and safety of rituximab biosimilar in refractory lupus
by: Nantakarn Pongtarakulpanit, et al.
Published: (2020-12-01)

Rituximab in the treatment of refractory lupus nephritis with vasculitis
by: Huseyin Kadikoy, et al.
Published: (2012-01-01)

Rituximab reduces the hospitalization in patients with systemic lupus erythematosus
by: López Longo J, et al.
Published: (2010-11-01)

Severe neuropsychiatric systemic lupus erythematosus successfully treated with rituximab: an alternative to standard of care
by: Chessa E, et al.
Published: (2017-09-01)

RITUXIMAB TREATMENT EFFICACY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS REFRACTORY TO STANDARD THERAPY IN THE LONG-TERM FOLLOW-UP
by: M. E. Tsanyan, et al.
Published: (2014-06-01)

Safety and efficacy of rituximab in refractory pediatric Systemic Lupus Erythematosus nephritis: a single-center experience of northern Greece
by: Tzimouli V, et al.
Published: (2011-09-01)

A case of developing progressive multifocal leukoencephalopathy while using rituximab and mycophenolate mofetil in refractory systemic lupus erythematosus
by: Ishikawa Y, et al.
Published: (2018-06-01)

Mycophenolate mofetil as an immunomodulator in refractory noninfectious uveitis
by: Ever Ernesto Caso Rodriguez, et al.

Noninfectious, Severe Cryoglobulinemic Vasculitis with Renal Involvement – Safety and Efficacy of Long-Term Treatment with Rituximab
by: Leśniak K, et al.
Published: (2021-07-01)

Sequential therapy with rituximab and belimumab in patients with systemic lupus erythematosus
by: A. A. Mesnyankina, et al.
Published: (2020-11-01)

Use of rituximab in systemic lupus erythematosus in children: a review
by: A. N. Arefyeva
Published: (2019-11-01)

Efficacy of Rituximab in a Systemic Lupus Erythematosus Patient Presenting with Diffuse Alveolar Hemorrhage
by: Gabriela Montes-Rivera, et al.
Published: (2017-01-01)

Rituximab for treatment of severe lupus nephritis
by: Baskin E, et al.
Published: (2008-09-01)

Atypical Presenting Symptoms of Acute Onset Systemic Lupus Erythematosus with Enteritis and Cystitis
by: Mayu Yagita, et al.
Published: (2016-01-01)

Early addition of rituximab in the management of myositis associated with systemic lupus erythematosus
by: Mervat E Behiry, et al.
Published: (2019-01-01)

Rituximab reduces anti-cardiolipin levels in patients with systemic lupus erythematosus
by: Carreño L, et al.
Published: (2010-11-01)

Steroid-resistant autoimmune thrombocytopenia in systemic lupus erythematosus treated with rituximab
by: Vasudha V Sardesai, et al.
Published: (2015-01-01)

B-cell targeted therapy in systemic lupus erythematosus: potential of rituximab
by: Wiesik-Szewczyk E, et al.
Published: (2012-09-01)

Use of rituximab as a treatment for systemic lupus erythematosus: retrospective review
by: Roberta Ismael Lacerda Machado, et al.

Successful Treatment with Rituximab in a Patient with Castleman′s Disease Complicated by Systemic Lupus Erythematosus and Severe Autoimmune Thrombocytopenia
by: Lu Zhang, et al.
Published: (2015-01-01)

Adverse infusion reactions to rituximab in systemic lupus erythematosus: a retrospective analysis
by: Ashleigh Hennessey, et al.
Published: (2019-08-01)

Successful Treatment of Urticarial Vasculitis in a Patient With Systemic Lupus Erythematosus With Rituximab
by: Samar Alharbi, et al.
Published: (2020-10-01)

Efficacy and safty of Dexamethasone intravitreal implant in noninfectious refractory uveitis
by: Qing-Shan Chen, et al.
Published: (2021-06-01)

Refractory Angioedema in a Patient with Systemic Lupus Erythematosus
by: Zahra Habibagahi, et al.
Published: (2015-07-01)

Splenectomy for refractory thrombocytopenia in juvenile systemic lupus erythematosus
by: Campos LMA, et al.
Published: (2008-09-01)

Anti-C1q antibodies in patients with systemic lupus erythematosus treated by rituximab
by: M É Tsanian, et al.
Published: (2013-05-01)

Intravitreal Dexamethasone Implants for Refractory Macular Edema in Eyes with Noninfectious Uveitis
by: Eugene Yu-Chuan Kang, et al.
Published: (2021-08-01)

Allogeneic Mesenchymal Stem Cell Transplantation in Severe and Refractory Systemic Lupus Erythematosus: 4 Years of Experience
by: Dandan Wang, et al.
Published: (2013-12-01)

Intravenous Rituximab in Severe Refractory Primary Focal Segmental Glomerulosclerosis
by: Wee Leng Gan, et al.
Published: (2018-10-01)